Liu L, Zhao Y, Huang Z, Long Z, Qin H, Lin H
Anim Nutr. 2025; 20:1-22.
PMID: 39949731
PMC: 11815959.
DOI: 10.1016/j.aninu.2024.10.005.
Zhou S, Zhao Z, Wang Z, Xu H, Li Y, Xu K
J Transl Med. 2025; 23(1):50.
PMID: 39806363
PMC: 11727299.
DOI: 10.1186/s12967-025-06071-8.
Scalavino V, Piccinno E, Labarile N, Armentano R, Giannelli G, Serino G
Int J Mol Sci. 2024; 25(15).
PMID: 39126032
PMC: 11312748.
DOI: 10.3390/ijms25158463.
Li Q, Wang J
Nutrients. 2024; 16(14).
PMID: 39064745
PMC: 11280054.
DOI: 10.3390/nu16142302.
Feng J, Chen J, Li X, Ren X, Chen J, Li Z
Front Genet. 2024; 15:1383162.
PMID: 39005628
PMC: 11240141.
DOI: 10.3389/fgene.2024.1383162.
Aspergillus awamori: potential antioxidant, anti-inflammatory, and anti-apoptotic activities in acetic acid-induced ulcerative colitis in rats.
Abd-Ellatieff H, Georg K, Abourawash A, Ghazy E, Samak D, Goda W
Inflammopharmacology. 2024; 32(4):2541-2553.
PMID: 38763983
PMC: 11300502.
DOI: 10.1007/s10787-024-01489-w.
MicroRNA 429 regulates MMPs expression by modulating TIMP2 expression in colon cancer cells and inflammatory colitis.
Han S, Mo J, Yun K, Chae S
Genes Genomics. 2024; 46(7):763-774.
PMID: 38733517
DOI: 10.1007/s13258-024-01520-y.
Circulatory resistin levels in inflammatory bowel disease: a systematic review and meta-analysis.
Behnoush A, Parmis Maroufi S, Reshadmanesh T, Kia Y, Norouzi M, Mohammadi S
BMC Gastroenterol. 2024; 24(1):107.
PMID: 38486190
PMC: 10941394.
DOI: 10.1186/s12876-024-03199-7.
Comparative treatment of Sulfasalazine+Ezetimibe combination and Sulfasalazine in a rat model with induced colitis.
Jaafar F, Abu-Raghif A
J Med Life. 2023; 16(8):1165-1169.
PMID: 38024826
PMC: 10652677.
DOI: 10.25122/jml-2023-0194.
Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study.
Dotti A, Magro D, Vilela E, Chebli J, Chebli L, Steinwurz F
Crohns Colitis 360. 2023; 5(4):otad053.
PMID: 37859629
PMC: 10583759.
DOI: 10.1093/crocol/otad053.
Cepharanthine Exerts Antioxidant and Anti-Inflammatory Effects in Lipopolysaccharide (LPS)-Induced Macrophages and DSS-Induced Colitis Mice.
Chen G, Wen D, Shen L, Feng Y, Xiong Q, Li P
Molecules. 2023; 28(16).
PMID: 37630322
PMC: 10458559.
DOI: 10.3390/molecules28166070.
Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study.
Nagata T, Funakoshi S, Morihara D, Shakado S, Yokoyama K, Takata K
Intest Res. 2023; 21(4):471-480.
PMID: 37559192
PMC: 10626015.
DOI: 10.5217/ir.2023.00035.
Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease.
Rezazadeh F, Ramos N, Saliganan A, Al-Hallak N, Chen K, Mohamad B
J Nucl Med. 2023; 64(11):1806-1814.
PMID: 37474270
PMC: 10626378.
DOI: 10.2967/jnumed.123.265649.
The role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in the diagnosis and severity of inflammatory bowel disease in children.
Zahmatkesh A, Sohouli M, Hosseini S, Rohani P
Eur J Pediatr. 2023; 182(9):4263-4270.
PMID: 37458815
DOI: 10.1007/s00431-023-05110-0.
Amelioration of Murine Colitis by Attenuated Encoding Interleukin-19.
Chen S, Chu C, Yang M, Lin J, Wang C, Lee C
Microorganisms. 2023; 11(6).
PMID: 37375032
PMC: 10304794.
DOI: 10.3390/microorganisms11061530.
The Effects of a High-Fat Diet on Inflammatory Bowel Disease.
Dang Y, Ma C, Chen K, Chen Y, Jiang M, Hu K
Biomolecules. 2023; 13(6).
PMID: 37371485
PMC: 10296751.
DOI: 10.3390/biom13060905.
Epigenetics of Inflammatory Bowel Diseases.
Toruner M, Unal N
Turk J Gastroenterol. 2023; 34(5):437-448.
PMID: 37158530
PMC: 10334590.
DOI: 10.5152/tjg.2023.22515.
Response Variability to Drug Testing in Two Models of Chemically Induced Colitis.
Suau R, Garcia A, Bernal C, Llaves M, Schiering K, Jou-Olle E
Int J Mol Sci. 2023; 24(7).
PMID: 37047397
PMC: 10094987.
DOI: 10.3390/ijms24076424.
The Role of Explored Ex Vivo In Vitro on Human Colon Biopsies from Ulcerative Colitis Patients.
Hajji N, Russo I, Bianco J, Piazza O, Iovino P, Santonicola A
Nutrients. 2023; 15(6).
PMID: 36986188
PMC: 10056518.
DOI: 10.3390/nu15061457.
What Do NAFLD, Liver Fibrosis, and Inflammatory Bowel Disease Have in Common? Review of the Current Literature.
Jarmakiewicz-Czaja S, Gruszecka J, Filip R
Metabolites. 2023; 13(3).
PMID: 36984818
PMC: 10051776.
DOI: 10.3390/metabo13030378.
